IPOPLUS

262.75

-7.1 -2.63%

18 Jun 2026

NSE Listed

Suven Life Sciences Limited (SUVEN)

Volume: 2,53,371Avg Vol 1W: 3,63,517.8Avg Vol 1M: 5,48,366.352W Range:124.11299.99
₹262.75 2.63%
Key Ratios
Updated 8h ago
Market Cap₹7,084 Cr
Current Price₹262.75
Previous Close₹269.85
High / Low (52w)₹299.99 / ₹124.11
Volume2,53,371
Avg Vol (1W)3,63,517.8
Avg Vol (1M)5,48,366.3
Stock P/E
Book Value₹22.43
Dividend Yield0%
ROE-46.7%
ROA-44.3%
Revenue (TTM)₹18 Cr
Revenue Growth-43.1%
Profit Margin-38.81%
Total Debt₹0 Cr
Shares Outstanding26 Cr
Face Value₹1
EPS (TTM)₹-2.02
P/B11.98
Debt / Equity0.03
50 DMA₹169.39
200 DMA₹189.12
Day change-2.63%
Price Chart
262.75 11.31% · 1Y
29612632.1L
2025-06-17
2026-05-11

20-day avg volume: 5.5L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 34% YoY.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹1 Cr₹3 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr
EBITDA₹-28 Cr₹-50 Cr₹-39 Cr₹-44 Cr₹-52 Cr₹-77 Cr₹-102 Cr₹-45 Cr
Net Profit₹-28 Cr₹-50 Cr₹-39 Cr₹-44 Cr₹-52 Cr₹-77 Cr₹-102 Cr₹-46 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹28 Cr₹21 Cr₹13 Cr₹22 Cr₹33 Cr₹18 Cr
EBITDA₹-106 Cr₹-77 Cr₹-125 Cr₹-124 Cr₹-113 Cr₹-161 Cr
Net Profit₹-94 Cr₹-72 Cr₹-122 Cr₹-118 Cr₹-105 Cr₹-161 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹182 Cr₹128 Cr₹108 Cr₹389 Cr₹285 Cr₹135 Cr
Total Liabilities₹39 Cr₹20 Cr₹12 Cr₹14 Cr₹15 Cr₹25 Cr
Equity₹143 Cr₹108 Cr₹96 Cr₹375 Cr₹270 Cr₹110 Cr
Total Debt₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-132 Cr₹-95 Cr₹-127 Cr₹-115 Cr₹-122 Cr₹-155 Cr
Investing₹146 Cr₹56 Cr₹-22 Cr₹-248 Cr₹94 Cr₹155 Cr
Financing₹3 Cr₹35 Cr₹146 Cr₹396 Cr₹-1 Cr₹-1 Cr
Free Cash Flow₹-132 Cr₹-95 Cr₹-127 Cr₹-115 Cr₹-122 Cr₹-155 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search